To The Moon

Since the outbreak of Covid-19, ‌$Paysign Inc(PAYS)$  ‌PAYS has suffered loss from Q2 2020 (except Q4 2021 with profit of $102 thousand) Thanks to the reopening of most of the plasma centers and increase plasma donation, in the latest quarter of Q3 2022, PAYS has finally reported a profit of $0.02 net profit per share for three months ended September 2022. Q2 net loss was $228 thousand; Q3 net income was $852 thousand. The nine months earning per share has also turned to positive of $ 0.01 per share.

It seem the environment has turned favourable in Q3 and now onwards:

- Onboard an additional 13 plasma centers exit in the quarter with a total of 450 centers utilizing their services, expect in remainder of the year to onboard an additional three to four centers each month for a total of 90 to 95 new centers in 2022.

- Load and spend trends improve as the number of plasma donations increased.

- Began to see the effects of the U.S. District Courts preliminary injunction on September 16, allowing Mexican nationals with a valid B1, B2 visa to resume donating plasma in the U.S.

- Signed two new prepaid disbursement programs.

- Awarded the business in an RFP sponsored by a nationwide membership organization to provide general purpose reloadable and gift cards to over 440 of their brick-and-mortar locations.

More than 90% of PAYS revenue was from plasma center, so more plasma donation equal to more revenue.